azoxymethane has been researched along with ro 24-5531 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bissonnette, M; Brasitus, TA; Hart, J; Khare, S; Sitrin, MD; Wali, RK | 1 |
| Aquino, B; Bissonnette, M; Brasitus, TA; Khare, S; Niedziela, S; Sitrin, M; Wali, RK | 1 |
2 other study(ies) available for azoxymethane and ro 24-5531
| Article | Year |
|---|---|
1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol, a noncalcemic analogue of 1 alpha,25-dihydroxyvitamin D3, inhibits azoxymethane-induced colonic tumorigenesis.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Calcitriol; Cell Transformation, Neoplastic; Colonic Neoplasms; Male; Rats; Rats, Inbred F344 | 1995 |
Protein kinase C isoforms in the chemopreventive effects of a novel vitamin D3 analogue in rat colonic tumorigenesis.
Topics: Adenocarcinoma; Adenoma; Animals; Anticarcinogenic Agents; Azoxymethane; Calcitriol; Chemoprevention; Colon; Colonic Neoplasms; Down-Regulation; Isoenzymes; Male; Protein Kinase C; Rats; Rats, Inbred F344; Up-Regulation | 1996 |